Mankind Pharma Limited Stock

Equities

MANKIND

INE634S01028

Pharmaceuticals

Delayed NSE India S.E. 06:26:50 2024-05-29 am EDT 5-day change 1st Jan Change
2,102 INR -0.57% Intraday chart for Mankind Pharma Limited -0.23% +6.05%
Sales 2024 103B 1.24B Sales 2025 * 116B 1.4B Capitalization 847B 10.16B
Net income 2024 19.13B 230M Net income 2025 * 22.08B 265M EV / Sales 2024 8.92 x
Net cash position 2024 * 25.25B 303M Net cash position 2025 * 42.36B 508M EV / Sales 2025 * 6.92 x
P/E ratio 2024
48.3 x
P/E ratio 2025 *
38.4 x
Employees 18,468
Yield 2024 *
0.29%
Yield 2025 *
0.27%
Free-Float 19.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.57%
1 week-0.23%
Current month-11.08%
1 month-11.55%
3 months-1.55%
6 months+10.73%
Current year+6.05%
More quotes
1 week
2 056.00
Extreme 2056
2 174.45
1 month
2 056.00
Extreme 2056
2 420.00
Current year
1 980.00
Extreme 1980
2 490.00
1 year
1 326.00
Extreme 1326
2 490.00
3 years
1 242.00
Extreme 1242
2 490.00
5 years
1 242.00
Extreme 1242
2 490.00
10 years
1 242.00
Extreme 1242
2 490.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 07-09-20
Director of Finance/CFO 55 16-06-16
Compliance Officer - 16-09-22
Members of the board TitleAgeSince
Director/Board Member 60 22-07-31
Director/Board Member 71 22-07-31
Director/Board Member 61 15-02-18
More insiders
Date Price Change Volume
24-05-29 2,102 -0.57% 781 782
24-05-28 2,114 +0.00% 610,496
24-05-27 2,114 +2.50% 959,693
24-05-24 2,063 -1.77% 713,692
24-05-23 2,100 -0.34% 762,526

Delayed Quote NSE India S.E., May 29, 2024 at 06:26 am EDT

More quotes
Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The Company offers exceptional healthcare solutions for a wide range of healthcare needs with a diverse portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system (CNS), vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. The Company's subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Broadway Hospitality Services Private Limited, Jaspack Industries Private Limited, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,114 INR
Average target price
2,237 INR
Spread / Average Target
+5.79%
Consensus
  1. Stock Market
  2. Equities
  3. MANKIND Stock